Professor of Hematology and Oncology, Emory University
Oncology
Dr. Dong M. Shin, MD
|
|
Give Review
Dong Shin practices Oncology. He graduated from Yonsei University College of Medicine. He has 6 awards "KBS Global Award in Science and Technology", "Best Doctors", "America's Top Doctors", "Atlanta Magazine: Top Doctors", "America's Top Doctors for Cancer" and "Super Doctor". Dong M. Shin, MD is a published doctor. He has 100 publications published. The most current publication "Fusion of lysosomes with secretory organelles leads to uncontrolled exocytosis in the lysosomal storage disease mucolipidosis type IV."
Publications
- Fusion of lysosomes with secretory organelles leads to uncontrolled exocytosis in the lysosomal storage disease mucolipidosis type IV.
- Designing a broad-spectrum integrative approach for Cancer prevention and treatment.
- Targeting HER (ERBB) signaling in head and neck Cancer: An essential update.
- Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.
- Targeting KRAS-mutant non-small cell lung Cancer: challenges and opportunities.
- A novel prediction model for human papillomavirus-associated oropharyngeal Squamous cell carcinoma using p16 and subcellular β-catenin expression.
- Fatigue is associated with inflammation in patients with head and neck Cancer before and after intensity-modulated radiation therapy.
- Predictors and outcomes of venous thromboembolism in hospitalized lung Cancer patients: A Nationwide Inpatient Sample database analysis.
- Evasion of anti-growth signaling: a key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.
- Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth.
- Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic Squamous cell carcinoma of the head and neck.
- Patients' perceptions of Complementary and Alternative Medicine in head and neck Cancer: A qualitative, pilot study with clinical implications.
- Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative On...
- Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced Squamous cell carcinomas of the head and neck (SCCHN): a systematic review.
- Human papillomavirus 16 oncoprotein regulates the translocation of β-catenin via the activation of epidermal growth factor receptor.
- Tyr-301 phosphorylation inhibits pyruvate dehydrogenase by blocking substrate binding and promotes the warburg effect.
- Targeted Iron-Oxide Nanoparticle for Photodynamic Therapy and Imaging of Head and Neck Cancer.
- Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma (HNSCC).
- Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck Cancer.
- Synthetic Curcumin Analog UBS Inhibits the Growth of Head and Neck Squamous Cell Carcinoma Xenografts.
- Chemoprevention of head and neck Cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study.
- Epidemiology of Head and Neck Squamous Cell Cancer Among HIV-Infected Patients.
- The Prometastatic Ribosomal S6 Kinase 2-cAMP Response Element-binding Protein (RSK2-CREB) Signaling Pathway Up-regulates the Actin-binding Protein Fascin-1 to Promote ...
- Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.
- RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy.
- Acetylated Tubulin (AT) as a Prognostic Marker in Squamous Cell Carcinoma of the Head and Neck.
- Paranasal sinus Squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results Data, 1973 to 2009.
- Acoustophoretic force-based compressibility measurement of Cancer cells having different metastatic potential.
- New Perspectives of Curcumin in Cancer Prevention.
- p90RSK2 mediates anti-anoikis signals by both transcription-dependent and -independent mechanisms.
- Convergence of IRBIT, phosphatidylinositol (4,5) bisphosphate, and WNK/SPAK kinases in regulation of the Na+-HCO3- cotransporters family.
- Phase II Study of Docetaxel in Combination with Everolimus for Second- or Third-Line Therapy of Advanced Non-Small-Cell Lung Cancer.
- N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for Cancer therapy.
- A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor Malignancies.
- Epidermal Growth Factor Promotes Protein Degradation of Epithelial Protein Lost in Neoplasm (EPLIN), a Putative Metastasis Suppressor, during Epithelial-mesenchymal Tr...
- Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid Cancer.
- Prognostic impact of Fas-associated death domain, a key component in death receptor signaling, is dependent on the presence of lymph node metastasis in head and neck s...
- Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.
- Interruption of nuclear localization of ATBF1 during the histopathologic progression of head and neck Squamous cell carcinoma.
- Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis ...
- Synthetic curcumin analog EF31 inhibits the growth of head and neck Squamous cell carcinoma xenografts.
- Laryngeal tumor volume as a predictor for thyroid cartilage penetration.
- The role of innate immunity in trafficking of hematopoietic stem Cells-an emerging link between activation of complement cascade and chemotactic gradients of bioactive...
- Targeted Delivery of Cisplatin to Lung Cancer Using ScFvEGFR-Heparin-Cisplatin Nanoparticles.
- Advances in the management of recurrent or metastatic Squamous cell carcinoma of the head and neck.
- A Dual-Targeting Antibody against EGFR-VEGF for Lung and Head and Neck Cancer Treatment.
- Pharmacodynamics of DT-IgG, a dual-targeting antibody against VEGF-EGFR, in tumor xenografted mice.
- The ERK MAPK/RSK1 cascade phosphorylates CREB to induce MUC5B gene expression via DP1 receptor signaling.
- A Reexamination of Active and Passive Tumor Targeting by Using Rod-Shaped Gold Nanocrystals and Covalently Conjugated Peptide Ligands.
- A Folate Receptor-Targeting Nanoparticle Minimizes Drug Resistance in a Human Cancer Model.
- Human immunodeficiency virus-associated lung Cancer in the era of highly active antiretroviral therapy.
- Carmustine induces ERK- and JNK-dependent Cell death of neuronally-differentiated PC12 Cells via generation of reactive oxygen species.
- Tumor cytotoxicity of 5,6-dimethyl-1,10-phenanthroline and its corresponding gold(III) complex.
- Patterns of extralaryngeal spread of laryngeal Cancer: Thyroid Cartilage Penetration Occurs in a Minority of Patients with Extralaryngeal Spread of Laryngeal Squamous ...
- Detection of circulating tumor Cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles.
- Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced Malignancies.
- Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53.
- Phase 1 and pharmacokinetic study of everolimus, a mammalian target of rapamycin inhibitor, in combination with docetaxel for recurrent/refractory nonsmall cell Lung c...
- Chemoprevention of head and neck Cancer with green tea polyphenols.
- What the mitochondria see.
- Cancer prevention with natural compounds.
- Prognostic accuracy of computed tomography findings for patients with laryngeal Cancer undergoing laryngectomy.
- Targeted deLivery of paclitaxel to tumor cells: synthesis and in vitro evaluation.
- p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck Squamous cell carcinoma cells.
- Restoration of p53 functions protects Cells from concanavalin A-induced apoptosis.
- Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck Squamous cell carcinoma and their prognostic impact.
- Oral Cancer prevention advances with a translational trial of green tea.
- Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced Squamous cell carcinoma of the larynx and oropharynx: a retrospective single-in...
- HFT-T, a targeting nanoparticle, enhances specific deLivery of paclitaxel to folate receptor-positive tumors.
- Sequence dependence of cell growth inhibition by EGFR-tyrosine kinase inhibitor ZD1839, docetaxel, and cisplatin in head and neck Cancer.
- Role of cyclooxygenase-2 in tumor progression and survival of head and neck Squamous cell carcinoma.
- TRPC channels as STIM1-regulated SOCs.
- Synergistic growth inhibition of Squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nucl...
- Perspectives for Cancer prevention with natural compounds.
- Durable long-term remission with chemotherapy alone for stage II to IV laryngeal Cancer.
- Native Store-operated Ca2+ Influx Requires the Channel Function of Orai1 and TRPC1.
- Examining expression of folate receptor in Squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug.
- Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck Cancer: first human application and potential antitumor mechanisms.
- Phase I trial of weekly topotecan and gemcitabine in patients with solid Tumors.
- Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in Oral premalignancy.
- Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor.
- Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck Squamous cell carcinoma: predictive and prognostic...
- Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced Squamous cell carcinoma of the tongue base.
- Therapeutic nanoparticles for drug delivery in Cancer.
- Application of nanotechnology in Cancer therapy and imaging.
- Head and neck Cancer chemoprevention gets a shot in the arm.
- In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags.
- Enhancement of docetaxel-induced cytotoxicity by blocking epidermal growth factor receptor and cyclooxygenase-2 pathways in Squamous cell carcinoma of the head and neck.
- Phase I clinical and pharmacodynamic evaluation of oral CI-1033 in patients with refractory Cancer.
- Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-alpha2a, and alpha-tocopherol in Squamous cell carcinoma of ...
- Down-regulation of S100A2 in lymph node metastases of head and neck Cancer.
- Moving toward bioadjuvant approaches to head and neck Cancer prevention.
- Nanotechnology in Cancer therapeutics: bioconjugated nanoparticles for drug delivery.
- Fenretinide activity in retinoid-resistant Oral leukoplakia.
- Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck Cancer patients.
- Radiotherapy plus cetuximab for Squamous-cell carcinoma of the head and neck.
- Targeting the epidermal growth factor receptor. Trials in head and neck and lung Cancer.
- A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal Carcinoma.
- Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model.
Schools
YonSei University College Of Medicine
Yonsei University Hospital
Cook Co Hospital
University Tex MD Anderson Hospital
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Breast Cancer
- Colorectal Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- KBS Global Award in Science and Technology
- Best Doctors
- America's Top Doctors
- Atlanta Magazine: Top Doctors
- America's Top Doctors for Cancer
- Super Doctor
Education
-
University of Texas MD Anderson Cancer Center -
John H. Stroger Hospital of Cook County -
Yonsei University College of Medicine
Hospital
-
Emory University Hospital -
Emory University Hospital Midtown -
Grady Memorial Hospital
Drug Facts
| NPI NUMBER | 1740398395 | |
| NPPES Provider LastName | SHIN | |
| NPPES Provider FirstName | DONG | |
| NPPES Provider ZIPCode | 303221013 | |
| NPPES Provider State | GA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 281.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 76.0 | |
| Percent Opioid Claims | 27.05 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1740398395 |
| Last Name Of The Provider | SHIN |
| First Name Of The Provider | DONG |
| View All |
Similar Doctors
|
|
Dr. Sanford H. Schwartz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arielle C. Lutterman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gina Z. D Amato, MD |
|
|
Dr. Leroy Fass, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul L. Richter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suresh S. Ramalingam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ruth M. O'Regan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bamidele A. Adesunloye, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melvin R. Moore, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ross M. Michels, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Divya Tiwari, MD
This Doctor is OpenDoctor Recommended.
|